Abstract
Myristoyl CoA:Protein N-myristoyltransferase (NMT) is the enzyme which catalyses the covalent transfer of myristate from myristoyl CoA to the amino-terminal glycine residue of protein substrates. Although NMT is ubiquitous in eukaryotic cells, the enzyme levels and cellular distribution vary among tissues. In this article, we describe the properties of mammalian NMT(s) with reference to subcellular distribution, molecular weights, substrate specificity and the possible involvement of NMT in pathological processes. The cytosolic fraction of bovine brain contains multiple forms of NMT activity whereas bovine spleen contains only a single form. In bovine brain and spleen, the cytosol contained majority of NMT activity. In contrast, rabbit colon and rat liver NMT activity was predominantly particulate. Regional differences in NMT activity have been observed in both rabbit intestine and bovine brain. Results from our laboratory along with the existing knowledge, provide evidence for the existence of tissue specific isozymes of NMT.
Similar content being viewed by others
Abbreviations
- NMT:
-
myristoyl CoA: protein N-myristoyltransferase
- NIP71 :
-
71 kDa heat stable N-myristoyltransferase inhibitor protein
- HIV-1:
-
human immunodeficiency virus 1
- MoMLV:
-
Moloney Murine Leukaemia virus
- SDS:
-
sodium dodecyl sulfate
References
Magee AI, Koyama AH, Mafler C, Wen D, Schlesinger MJ: Release of fatty acids from various glycoproteins by hydroxylamine. Biochim Biophys Acta 798: 156–166, 1984
Olson EM, Towler DA, Glaser L: Specificity of fatty acid acylation of cellular proteins. J Biol Chem 260: 3784–3790, 1985
Dunphy WG, Fries E, Urbani LJ, Rothman JE: Early and late functions associated with the Golgi apparatus reside in distinct compartments. Proc Natl Acad Sci USA 78: 7453–7457, 1981
Quinn P, Griffiths G, Warren G: Dissection of the Golgi complex II. Density separation of specific Golgi function in virally infected cells treated with monensin. J Cell Biol 96: 851–856, 1983
Schmidt MFG, Schlesinger MJ: Relation of fatty acid attachment to the translation and maturation of vesicular stomatitis and sindbis virus membrane glycoprotein. J Biol Chem 259: 3334–3339, 1980
Carr SA, Biemann K, Shoji S, Parmelee DC, Titani K:n-tetradeconyl is the NH2-terminal blocking group of the catalytic subunit of cyclic AMP dependent protein kinase from bovine cardiac muscle. Proc Natl Acad Sci USA 79: 6128–6131, 1982
Aitken A, Cohen P, Santikaran S, Williams DH, Calder AG, Smith A, Klee CB: Identification of the NH2 terminal blocking group of calcineurin B as myristic acid. FEBS Lett 150: 314–318, 1982
Schultz A, Henderson LE, Oroszlan S, Garber EA, Hanafusa H: Amino terminal myristoylation of protein kinase p60src a retroviral transforming protein. Science 227: 427–429, 1985
Boyle JJ, Ludwig EH: Analysis of fatty acids of continuously cultured mammalian cells by gas-liquid chromatography. Nature 196: 893–894, 1962
Towler DA, Gordon JI, Adams SP, Glaser L: The biology and enzymology of eukaryotic protein acylation. Annu Rev Biochem 57: 69–99, 1988
Rudnick DA, Mcwherter CA, Gokel GW, Gordon JI: Myristoyl CoA: protein N-myristoyltransferase. Adv Enzymol Relat Area Mol Biol 67: 375–430, 1993
Duronio RJ, Rudnick DA, Knoll LJ, Johnson DR, Gordon JI: N-myristoylation of proteins: Studies withSaccharomyces cerevisiae as a model system. In: M.J. Schlesinger (ed.). Lipid modification of proteins, CRC Press, London, Tokyo, pp 21–57, 1993
Grand RAJ: Acylation of viral and eukaryotic proteins. Biochem J 258: 625–628, 1989
Ozols J, Carr SA, Strittmatter P: Identification of the NH2 terminal blocking group of NADH-cytochrome b5 reductase as myristic acid and the complete amino acid sequence of the membrane-binding domain. J Biol Chem 259: 13349–13354, 1984
Marchildon GA, Casnellie JE, Walsh KA, Krebs EG: Covalently bound myristate in a lymphoma tyrosine protein kinase. Proc Natl Acad Sci USA 81: 7679–7682, 1984
Sukegawa J, Semba K, Yamanashi Y, Nishizawa M, Miyajima N, Yamamoto T, Toyoshima K: Characterization of cDNA clones for the human c-yes gene. Mol Cell Biol 7: 41–47, 1987
Semba K, Nishizawa M, Miyajima N, Yoshida MC, Sukegawa J, Yamanashi Y, Saski M, Yamamoto T, Yoyoshima K:yes-related protooncogene,syn, belongs to the protein tyrosine kinase family. Proc Natl Acad Sci USA 83: 5459–5463, 1986
Schutz AM, Tsai SC, Kung HF, Oroszlan S, Moss J, Vaughan M: Hydroxylamine-stable covalent linkage of myristic acid in Goα, a guanine nucleotide-binding protein of bovine brain. Biochem Biophys Res Commun 146: 1234–1239, 1987
Liu J, Sessa WC: Identification of covalently bound aminoterminal myristic acid in endothelial nitric oxide synthase. J Biol Chem 269: 11691–11694, 1994
Aderem AA, Albert KA, Keum Mm, Wang JKT, Greengard P, Cohn ZA: Stimulus-dependent myristoylation of a major substrate for protein kinase C. Nature 332: 362–364, 1988
Wice BM, Gordon JI: A strategy for isolation of cDNA encoding proteins affecting human intestinal epithelial cell growth and differentiation: Characterization of a novel gut-specific N-myristoylated annexin. J Cell Biol 116: 405–422, 1992
Takamatsu K, Noguchi T: Hippocalcin: a calcium-binding protein of the EF-hand superfamily dominantly expressed in the hippocampus. Neurosci Res 17: 291–294, 1993
Brown HA, Gutowski S, Moomaw CR, Slaughter C, Sternweis PC: ADP-ribosylation factor, a small GTP-dependent regulatory protein stimulates phospholipase D activity. Cell 75: 1137–1144, 1993
Van Etten RA, Jackson PK, Baltimore D, Sanders MC, Matsudaira PT, Janmey PA: The COOH terminus of the c-Abl tyrosine kinase contains distinct F-and G-actin binding domains with bundling activity. J Cell Biol 124: 325–340, 1994
Kataoka M, Mihara K, Tokunaga F: Recoverin alters its surface properties depending on both calcium-binding and N-terminal myristoylation. J Biochem (Tokyo) 114: 535–540, 1993
Kitamoto Y, Yuan X, Wu Q, McCourt DW, Sadler JE: Enterokinase, the initiator of intestinal digestion, is a mosaic protease composed of a distinctive assortment of domains. Proc Natl Acad Sci USA 91: 7588–7592, 1994
Kobayashi M, Takamatsu K, Fujishiro M, Saitoh S, Noguchi T: Molecular cloning of a novel calcium-binding protein structurally related to hippocalcin from human brain and chromosomal mapping of its gene. Biochim Biophys Acta 1222: 515–518, 1994
Maekawa S, Matsuura Y, Nakamura S: Expression and myristoylation of NAP-22 using a baculovirus transfer vector system. Biochim Biophys Acta 1218: 119–122, 1994
Pullman WE, Bodmer WF: Cloning and characterization of a gene that regulates cell adhesion. Nature 356: 529–532, 1992
Henderson LF, Krutzsch HC, Oroszlan S: Myristoyl amino-terminal acylation of murine retrovirus proteins: An unusual post translational protein modification. Proc Natl Acad Sci USA 80: 339–343, 1983
Veronese FD, Copeland TD, Oroszland S, Gallo RC, Sarangadharan MG: Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24. J Virol 62: 795–801, 1988
Persing DH, Varmus HE, Ganem D: The preS1 protein of hepatitis B virus is acylated at its amino teminus with myristic acid. J Virol 61: 1672–1677, 1987
Streuli CH, Griffin BE: Myristic acid is coupled to a structural protein of polyoma virus and SV40. Nature 326: 619–622, 1987
Chow M, Newman JFE, Filman D, Hogle JM, Rowlands DJ, Brown F: Myristoylation of picornavirus capsid protein VP4 and its structural significance. Nature 327: 482–486, 1987
Buss JE, Mumby SM, Casey PJ, Gillman AG, Sefton BM: Myristoylated α-subunits of guanine nucleotide binding regulatory proteins. Proc Natl Acad Sci USA 84: 7493–7497, 1987
Rein A, McClure MR, Rice NR, Luftig RB, Schultz AM: Myristoylation site in pr65gag is essential for virus particle formation by Moloney murine leukaemia virus. Proc Natl Acad Sci USA 83: 7246–7250, 1986
Marc D, Drugeon G, Haenni AL, Girard M, Van der Werf S: Role of myristoylation of poliovirus capsid protein VP4 as determined by site directed mutagenesis of its N-terminal sequence. EMBO J 8: 2661–2668, 1989
Bryant ML, Ratner L: Myristoylation dependent replication and assembly of human immunodeficiency virus 1. Proc Natl Acad Sci USA 87: 523–527, 1990
Towler DA, Eubanks SR, Towery DS, Adams SP, Glaser L: Amino terminal processing of proteins by N-myristoylation: Substrate specificity of N-myristoyltransferase. J Biol Chem 262: 1030–1036, 1987
Kamps MP, Buss JE, Sefton BM: Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation. Proc Natl Acad Sci USA 82: 4625–4628, 1985
Kemps MP, Buss JE, Sefton BM: Rous sarcoma virus transforming protein lacking myristic acid phosphorylates known polypeptide susbstrates without inducing transformation. Cell 45: 105–112, 1986
Resh MD, Ling H: Identification of a 32K plasma membrane protein that binds to the myristoylated amino-terminal sequence of p60v-src. Nature 364: 84–86, 1990
Alland L, Peseckis SM, Atherton RE, Berthiaume L, Resh MD: Dual myristylation and palmitylation of Src family member p59fym affects subcellular localization. J Biol Chem 269: 16701–16705, 1994
Schmidt MFG: Fatty acylation of proteins. Biochim Biophys Acta 988: 411–426, 1989
Clegg CH, Ran W, Uhler MD, McKnight GS: A mutation in the catalytic subunit of protein kinase A prevents myristoylation but does not inhibit biological activity. J Biol Chem 264: 20140–20146 1989
Wiemann C, Wider G, von Freyberg B, Traber R, Braun W, Widmer H, Wuthrich K: The NMR structure of cyclosporin A bound to cyclophilin in aqueous solution. Biochemistry 30: 6563–6574, 1991
Manenti S, Sorokine O, Van Dorsselaer A, Taniguchi H: Isolation of the non-myristoylated form of a major substrate of protein kinase-C (MARCKS) from bovine brain. J Biol Chem 268: 6878–6881, 1993
McIlhinney RAJ, McGlone K: Evidence for a non-myristoylated pool of the 80 kDa protein kinase substrate of rat brain. Biochem J 271: 681–685, 1990
Towler DA, Adams SP, Eubanks SR, Towery DS, Jackson-Machelski E, Glaser L, Gordon JI: Purification and characterization of myristoyl CoA: protein N-myristoyltransferase. Proc Natl Acad Sci USA 84: 2708–2712, 1987
Duronio RJ, Towler DA, Heuckeroth RO, Gordon JI: Disruption of the yeast N-myristoyl transferase gene causes recessive lethality. Science 243: 796–800, 1989
Towler DA, Glaser L: Protein fatty acid acylation. Enzymatic synthesis of an N-myristoylglycyl peptide. Proc Natl Acad Sci USA 83: 2812–2816, 1986
Towler DA, Adams SP, Eubanks SR, Towery DS, Jackson-Machelski E, Glaser L, Gordon JI: Myristoyl CoA: protein N-myristoyl-transferase activities from rat liver and yeast possess overlapping yet distinct peptide substrate specificities. J Biol Chem 263: 1784–1790, 1988
Heuckeroth RO, Towler DA, Adams SP, Glaser L, Gordon JI: 11-(Ethylthio)undecanoic acid. A myristic acid analog of altered hydrophobicity which is functional for peptide N-myristoylation with wheat germ and yeast acyltransferase. J Biol Chem 263: 2127–2133, 1988
Boutin JA, Ferry G, Ernould AP, Maes P, Remond G, Vincent M, Atassi G: Myristoyl CoA: protein N-myristoyltransferase activity in cancer cells. Purification and characterization of a cytosolic isoform from the murine leukaemia cell line L1210. Eur J Biochem 214: 853–867, 1993
McIlhinney RAJ, McGlone K: Characterization of myristoyl CoA: glycylpeptide N-myristoyltransferase activity in rat brain: Subcellular and regional distribution. J Neurochem 54: 110–117, 1990
Glover CJ, Goddard C, Felsted RL: N-myristoylation of p60src. Biochem J 250: 485–491, 1988
King MJ, Sharma RK: N-myristoyl transferase assay using phosphocellulose paper binding. Anal Biochem 199: 149–153, 1991
King MJ, Sharma RK: Demonstration of multiple forms of bovine brain myristoyl CoA: protein N-myristoyltransferase. Mol Cell Biochem 113: 77–81, 1992
Duronio RJ, Reed SI, Gordon JI: Mutations of human myristoyl CoA: protein N-myristoyltransferase cause temperature-sensitive myristic acid auxotrophy inSaccharomyces cerevisiae. Proc Natl Acad Sci USA 89: 4129–4133, 1992
McIlhinney RAJ, McGlone K, Willis AC: Purification and partial sequencing of myristoyl CoA: protein N-myristoyltransferase from bovine brain. Biochem J 290: 405–410, 1993
Raju RVS, Kalra J, Sharma RK: Purification and properties of bovine spleen N-myristoyl CoA: protein N-myristoyltransferase. J Biol Chem 269: 12080–12083, 1994
McIlhinney RAJ, Patel PB, McGlone K: Characterization of a polyhistidine-tagged form of human myristoyl-CoA: protein N-myristoyltransferase produced inEscherichia coli. Eur J Biochem 222: 137–146, 1994
King MJ, Pugazhenthi S, Khandelwal RL, Sharma RK: Elevated N-myristoyltransferase activity is reversed by sodium orthovanadate in streptozotocin induced diabetic rat. Biochim Biophys Acta 1165: 259–262, 1993
Knoll LJ, Levy MA, Stahl PD, Gordon JI: Analysis of the compartmentalization of myristoyl CoA: protein N-myristoyltransferase inSaccharomyces cerevisiae. J Biol Chem 267: 5366–5373, 1992
Wilcox C, Hu JS, Olson EN: Acylation of proteins with myristic acid occurs cotranslationally. Science 238: 1275–1278, 1987
Magnuson BA, Raju RVS, Sharma RK: N-myristoyltransferase activity in normal rabbit intestine. Faseb J 8: A2024, 1994
King MJ, Sharma RK: Mechanisms of action of NIP71 on N-myristoyltransferase activity. Mol Cell Biochem 141: 79–86, 1994
Iozzo RV, Kovalszky I, Hacobian N, Schick PK, Ellingson JS, Dodge GR: Fatty acylation of heparin sulfate proteoglycan from human colon carcinoma cells. J Biol Chem 265: 19980–19989, 1990
Rosque WJ, McWherter CA, Wood DC, Gordon JI: A comparative analysis of the kinetic mechanism and peptide substrate specificity of human andSaccharomyces cerevisiae myristoyl CoA: protein N-myristoyltransferase. J Biol Chem 268: 9964–9971, 1993
King MJ, Sharma RK: Identification, purification and characterization of a membrane-associated N-myristoyltransferase inhibitor protein from bovine brain. Biochem J 291: 635–639, 1993
Hatefi Y, Hanstein WG: Destabilization of membranes with chaotropic ions. Methods Enzymol 31: 770–790, 1974
Davis KA, Hatefi Y: Kinetics of the resolution of complex I (Reduced Diphosphopyridine Nucleotide — Coenzyme Q Reductase) of the mitochondrial electron transport system by chaotropic agents. Biochemistry 8: 3355–3361, 1969
Holtzer A, Wang TY, Noelken ME: The effect of various monovalent anions on myosin B solutions. The identification of actin as a product of ATP action. Biochim Biophys Acta 42: 453–461, 1960
Wolff J: The effect of thyroxine on isolated dehydrogenase. J Biol Chem 237: 230–235, 1962
Cammack RR, Rao KK, Hall DO: Effect of chaotropic agents on the spectroscopic properties of spinach ferredoxin. Biochem Biophys Res Commun 44: 8–14, 1971
Gordon JA: Denaturation of globular proteins. Interaction of guanidinium salts with three proteins. Biochemistry 11: 1862–1870, 1972
Nicolau J, Bacila M: N-Acylsarcosines as inhibitors of respiration and glycolysis and glycolytic enzymes. Arch Biochem Biophys 129: 357–361, 1969
Raju RVS, King MJ, Kalra J, Sharma RK: Demonstration of two forms of myristoyl CoA: protein N-myristoyltransferase in bovine heart. Faseb J 7: A1196, 1993
Stevenson FT, Bursten SL, Loclsley RM, Lovett DH: Myristoyl acylation of the tumour necrosis factor a precursor on specific lysine residues. J Exp Med 176: 1053–1062, 1992
Muszbek L, Laposata M: Myristoylation of proteins in platelets occurs predominantly through thioester linkages. J Biol Chem 268: 8251–8255, 1993
da Silva AM, Klein CA: Rapid posttraslational myristoylation of 68 kDa protein inD. discoidedum. J Cell Biol 111: 401–407, 1990
Manenti S, Sorokine O, Dorsselaer AV, Taniguchi H: Demyristoylation of the major substrate of protein kinase C (MARCKS) by the cytoplasmic fraction of brain synaptosomes. J Biol Chem 269: 8309–8313, 1994
McIlhinney RAJ, McGlone K: A simple assay for the enzyme responsible for the attachment of myristic acid to the N-terminal glycine residue of proteins, myristoyl CoA: glycylpeptide N-myristoyltransferase. Biochem J 263: 387–391, 1989
Felsted RL, Goddard C, Glover CJ: N-myristoylation as a novel molecular target for the design of chemotherapeutic drugs. In: Cancer chemotherapy, Vol II, CRC Press Inc, pp 95–115
King MJ, Pugazhenthi S, Khandelwal RL, Sharma RK: Membrane associated N-myristoyltransferase activity is reduced in obese (fa/fa) Zucker rat liver. Biochem Biophys Res Commun 197: 665–670, 1993
Bryant ML, Heuckeroth RO, Kimata JT, Ratner L, Gordon JI: Replication of human immunodeficiency virus 1 and Moloney murine leukaemia virus is inhibited by different heteroatom containing analogs of myristic acid. Proc Natl Acad Sci USA 86: 8655–8659, 1989
Zheng GQ, Hu X, Cassady JM, Paige LA, Geahlen RL: Synthesis of myristoyl CoA analogues and myristoyl peptides as inhibitors of myristoyl CoA: protein N-myristoyltransferase. J Pharm Sci 82: 233–238, 1994
Aderem AA, Keum MM, Pure E, Cohn ZA: bacterial lipopolysaccharides, phorbol myristate acetate, and zymosan induce the myristoylation of specific macrophage proteins. Proc Natl Acad Sci USA 83: 5817–5821, 1986
Malvoisin E, Wild F, Zwingelstein G: 12-O-Tetradecanoyl phorbol 13-acetate stimulates the myristoylation of an 82 kDa protein in HL-60 cells. FEBS Lett 215: 175–178, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Raju, R.V.S., Magnuson, B.A. & Sharma, R.K. Mammalian myristoyl CoA: protein N-myristoyltransferase. Mol Cell Biochem 149, 191–202 (1995). https://doi.org/10.1007/BF01076577
Issue Date:
DOI: https://doi.org/10.1007/BF01076577